A Win For Kiora Pharmaceuticals Inc.
Thu, Feb 01, 2024 at 07:24 PM
Kiora Pharmaceuticals Inc. (KPRX:NASDAQ) soared at $0.85, a gain of 53.9%. On Thu, Feb 01, 2024, KPRX:NASDAQ touched a New 2-Week High of $0.85. The stock got featured on our News Catalysts scanner on Thu, Feb 01, 2024 at 03:23 AM in the 'PRIVATE PLACEMENT' category. From Thu, Jan 18, 2024, the stock recorded 40.00% Up Days and 81.82% Green Days
About Kiora Pharmaceuticals Inc. (KPRX:NASDAQ)
Kiora Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye.
Top 10 Gainers:
- NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ), 67.28%
- Kiora Pharmaceuticals Inc. (KPRX:NASDAQ), 53.87%
- Trio Petroleum Corp. (TPET:NYSEMKT), 46.16%
- Ostin Technology Group Co. Ltd. (OST:NASDAQ), 45.85%
- WaveDancer Inc. (WAVD:NASDAQ), 44.74%
- Akso Health Group (AHG:NASDAQ), 35.67%
- Asset Entities Inc. (ASST:NASDAQ), 34.78%
- Atara Biotherapeutics, Inc. (ATRA:NASDAQ), 33.1%
- Roadzen Inc Ord Cl A (RDZN:NASDAQ), 29.41%
- Celularity Inc. (CELU:NASDAQ), 28.45%